Suzlon to supply 21 MW turbines to biotech firm

Suzlon Energy today won an order from  a biotech firm to supply 10 turbines of 2.1 MW capacity each.

Under the agreement, Suzlon will supply, set up, operate and maintain the S88 wind turbines for Serum Institute of India in Pune.

With the new order, total renewable energy portfolio of the biotech company Serum Institute will increase to 60 MW, it said.

"As an organisation we are committed to the conservation of the environment and are constantly seeking ways to reduce the carbon footprint from our business operations. We see wind as a smart option with its techno-economic maturity and comparatively lower risks," Serum Institute chairman Cyrus Poonawalla said.

Serum Institute of India is a leading biotech company and among the world's largest makers of paediatric vaccines as well as of measles and DTP group of vaccines.